Bacteriophage-mediated decolonization of Klebsiella pneumoniae in a novel Galleria mellonella gut colonization model with Enterobacteriaceae.

Kamran A Mirza, Sandor Nietzsche, Oliwia Makarewicz, Mathias W Pletz, Lara Thieme
Author Information
  1. Kamran A Mirza: Jena University Hospital, Institute of Infectious Diseases and Infection Control, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany. kamran.mirza@med.uni-jena.de.
  2. Sandor Nietzsche: Center for Electron Microscope, Jena University Hospital, Ziegelmühlenweg 1, 07743, Jena, Germany.
  3. Oliwia Makarewicz: Jena University Hospital, Institute of Infectious Diseases and Infection Control, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.
  4. Mathias W Pletz: Jena University Hospital, Institute of Infectious Diseases and Infection Control, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.
  5. Lara Thieme: Jena University Hospital, Institute of Infectious Diseases and Infection Control, Friedrich-Schiller-University Jena, Am Klinikum 1, 07747, Jena, Germany.

Abstract

Galleria mellonella larvae have emerged as an invertebrate model for investigating bacterial pathogenesis and potential therapies, addressing ethical concerns related to mammalian models. This model has the advantage of having a simple gut microbiome, which is suitable for gut colonization studies. Intestinal colonization by Enterobacteriaceae significantly contributes to the spread of antibiotic resistance. This study aimed to establish a novel Enterobacteriaceae gut colonization larval model and assess its suitability for evaluating distinct antimicrobial efficacies. Larvae were force-fed sequentially with bacterial doses of K. pneumoniae and E. coli at 0, 24, and 48 h, with survival monitoring at 24 h intervals. Bacterial counts were assessed after 48 h and 120 h of force-feeding. Successfully colonized larvae were subjected to one-time force feeding of a bacteriophage cocktail (10 PFU/larvae) or MIC-based meropenem and ciprofloxacin. The colonized bacterial load was quantified by CFU count. Three doses of 10 CFU/larvae resulted in stable gut colonization, independent of the K. pneumoniae or E. coli strain. Compared with the control, force-feeding of the bacteriophage reduced the colonization of the strain Kp 419614 by 5 log CFU/larvae, while antibiotic treatment led to a 3 log CFU/larval reduction. This novel G. mellonella model provides a valuable alternative for gut colonization studies, facilitating proof-of-concept investigations and potentially reducing or replacing follow-up experiments in vertebrate models.

References

  1. Tacconelli, E. et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318–327 (2018). [DOI: 10.1016/S1473-3099(17)30753-3]
  2. Halpin, A. L. et al. Intestinal microbiome disruption in patients in a long-term acute care hospital: A case for development of microbiome disruption indices to improve infection prevention. Am. J. Infect. Control 44, 830–836 (2016). [DOI: 10.1016/j.ajic.2016.01.003]
  3. Ghose, C. et al. Clostridium difficile infection in the twenty-first century. Emerg. Microbes Infect. 2, 1–8 (2013). [DOI: 10.1038/emi.2013.62]
  4. Gordillo Altamirano, F. L. et al. Phage therapy in the postantibiotic era. Clin. Microbiol. Rev. 32, 10–1128 (2019). [DOI: 10.1128/CMR.00066-18]
  5. Cao, F. et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice. Biomed. Res. Int. 2015, 1–5 (2015).
  6. Kumari, S. et al. Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J. Med. Microbiol. 60, 205–210 (2011). [DOI: 10.1099/jmm.0.018580-0]
  7. Fang, Q. et al. Characterization of phage resistance and phages capable of intestinal decolonization of carbapenem-resistant Klebsiella pneumoniae in mice. Commun. Biol. 5, 48 (2022). [DOI: 10.1038/s42003-022-03001-y]
  8. Tannenbaum, J. et al. Russell and Burch’s 3Rs then and now: The need for clarity in definition and purpose. J. Am. Assoc. Lab. Anim. Sci. 54, 120–132 (2015). [PMID: 25836957]
  9. Ménard, G. et al. Galleria mellonella as a suitable model of bacterial infection: Past, present and future. Front. Cell. Infect. Microbiol. 11, 782733 (2021). [DOI: 10.3389/fcimb.2021.782733]
  10. Champion, O. L. et al. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis. Microbiology 155, 1516–1522 (2009). [DOI: 10.1099/mic.0.026823-0]
  11. Senior, N. J. et al. Galleria mellonella as an infection model for Campylobacter jejuni virulence. J. Med. Microbiol. 60, 661–669 (2011). [DOI: 10.1099/jmm.0.026658-0]
  12. Alenizi, D. et al. All Yersinia enterocolitica are pathogenic: Virulence of phylogroup 1 Y. enterocolitica in a Galleria mellonella infection model. Microbiology 162, 1379–1387 (2016). [DOI: 10.1099/mic.0.000311]
  13. Barnoy, S. et al. The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulence. Gut Microb. 8, 335–350 (2017). [DOI: 10.1080/19490976.2017.1293225]
  14. Lange, A. et al. A Galleria mellonella oral administration model to study commensal-induced innate immune responses. J. Vis. Exp. 145, e59270 (2019).
  15. Allonsius, C. N. et al. The microbiome of the invertebrate model host Galleria mellonella is dominated by Enterococcus. Anim. Microbiol. 1, 1–7 (2019). [DOI: 10.1186/s42523-019-0010-6]
  16. Gorodnichev, R. B. et al. Novel Klebsiella pneumoniae K23-specific bacteriophages from different families: Similarity of depolymerases and their therapeutic potential. Front. Microbiol. 12, 669618 (2021). [DOI: 10.3389/fmicb.2021.669618]
  17. Insua, J. L. et al. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect. Immun. 81, 3552–3565 (2013). [DOI: 10.1128/IAI.00391-13]
  18. Sugeçti, S. et al. Pathophysiological effects of Klebsiella pneumoniae infection on Galleria mellonella as an invertebrate model organism. Arch. Microbiol. 203, 3509–3517 (2021). [DOI: 10.1007/s00203-021-02346-y]
  19. Thiry, D. et al. New bacteriophages against emerging lineages ST23 and ST258 of Klebsiella pneumoniae and efficacy assessment in Galleria mellonella larvae. Viruses 11, 411 (2019). [DOI: 10.3390/v11050411]
  20. Kilkenny, C. et al. Improving bioscience research reporting: The arrive guidelines for reporting animal research. PLoS Biol. 8, 6 (2010). [DOI: 10.1371/journal.pbio.1000412]
  21. Glonti, T. et al. In vitro techniques and measurements of phage characteristics that are important for phage therapy success. Viruses 14, 1490 (2022). [DOI: 10.3390/v14071490]
  22. Kropinski, A. M. et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol. Biol. 501, 69–76 (2009). [DOI: 10.1007/978-1-60327-164-6_7]
  23. Dubourg, G. et al. Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics. Int. J. Antimicrob. Agents 44, 117–124 (2014). [DOI: 10.1016/j.ijantimicag.2014.04.020]
  24. Blaser, M. et al. Stop the killing of beneficial bacteria. Nature 476, 393–394 (2011). [DOI: 10.1038/476393a]
  25. Llor, C. et al. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 5, 229–241 (2014). [DOI: 10.1177/2042098614554919]
  26. Liu, J. Y. et al. Decolonization of carbapenem-resistant Klebsiella pneumoniae from the intestinal microbiota of model mice by phages targeting two surface structures. Front. Microbiol. 13, 877074 (2022). [DOI: 10.3389/fmicb.2022.877074]

MeSH Term

Animals
Anti-Bacterial Agents
Bacteria
Bacteriophages
Enterobacteriaceae
Escherichia coli
Klebsiella pneumoniae
Larva
Mammals
Moths

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0colonizationgutmodelmellonellabacterialEnterobacteriaceaenovelpneumoniaeGallerialarvaemodelsstudiesantibioticdosesKEcoli48 hforce-feedingcolonizedbacteriophagestrainlogemergedinvertebrateinvestigatingpathogenesispotentialtherapiesaddressingethicalconcernsrelatedmammalianadvantagesimplemicrobiomesuitableIntestinalsignificantlycontributesspreadresistancestudyaimedestablishlarvalassesssuitabilityevaluatingdistinctantimicrobialefficaciesLarvaeforce-fedsequentially024survivalmonitoring24 hintervalsBacterialcountsassessed120 hSuccessfullysubjectedone-timeforcefeedingcocktail10PFU/larvaeMIC-basedmeropenemciprofloxacinloadquantifiedCFUcountThree10 CFU/larvaeresultedstableindependentComparedcontrolreducedKp4196145CFU/larvaetreatmentled3CFU/larvalreductionGprovidesvaluablealternativefacilitatingproof-of-conceptinvestigationspotentiallyreducingreplacingfollow-upexperimentsvertebrateBacteriophage-mediateddecolonizationKlebsiella

Similar Articles

Cited By